MH
Matthew Harrison Morgan Stanley Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Denali Therapeutics
DNLI
$2.26B
| $15.43 | $30 |
94%
upside
| Overweight |
18 Aug ‘25
21 days ago |
|
2
Insmed
INSM
$30.7B
| $145.10 | $126 |
13%
downside
| Equal-Weight |
13 Aug ‘25
26 days ago |
|
3
Legend Biotech
LEGN
$6.66B
| $36.08 | $83 |
130%
upside
| Overweight |
12 Aug ‘25
27 days ago |
|
4
IO Biotech
IOBT
$128M
| $1.95 | $4 |
105%
upside
| Overweight |
12 Aug ‘25
27 days ago |
|
5
Vertex Pharmaceuticals
VRTX
$102B
| $396.12 | $439 |
11%
upside
| Equal-Weight |
5 Aug ‘25
1 month ago |
|
6
Regeneron Pharmaceuticals
REGN
$60.8B
| $573.38 | $761 |
33%
upside
| Overweight |
4 Aug ‘25
1 month ago |
|
7
Biogen
BIIB
$20.6B
| $140.67 | $144 |
2%
upside
| Equal-Weight |
1 Aug ‘25
1 month ago |
|
8
argenx
ARGX
$45.9B
| $750.78 | $766 |
2%
upside
| Overweight |
1 Aug ‘25
1 month ago |
|
9
Sarepta Therapeutics
SRPT
$1.96B
| $18.71 | $20 |
7%
upside
| Equal-Weight |
29 Jul ‘25
1 month ago |
|
10
BioMarin Pharmaceuticals
BMRN
$11.1B
| $57.77 | $96 |
66%
upside
| Overweight |
22 Jul ‘25
1 month ago |
|
11
Gilead Sciences
GILD
$143B
| $115.05 | $135 |
17%
upside
| Overweight |
25 Apr ‘25
4 months ago |
|
12
Atea Pharmaceuticals
AVIR
$267M
| $3.37 | $6 |
78%
upside
| Equal-Weight |
11 Apr ‘25
5 months ago |
|
13
Moderna
MRNA
$9.78B
| $25.14 | $32 |
27%
upside
| Equal-Weight |
9 Apr ‘25
5 months ago |
|
14
Tenaya Therapeutics
TNYA
$220M
| $1.35 | $5 |
270%
upside
| Overweight |
12 Mar ‘25
6 months ago |
|
15
Alector
ALEC
$305M
| $3.01 | $3 |
0%
downside
| Underweight |
26 Nov ‘24
9 months ago |
|
|
CNTA
16
Centessa Pharmaceuticals
CNTA
$2.11B
| $15.73 | $11 |
30%
downside
| Equal-Weight |
21 Jun ‘24
1 year ago |
|
17
Zentalis Pharmaceuticals
ZNTL
$126M
| $1.75 | $8 |
357%
upside
| Equal-Weight |
18 Jun ‘24
1 year ago |
|
18
Editas Medicine
EDIT
$248M
| $2.76 | $7 |
154%
upside
| Equal-Weight |
9 May ‘24
1 year ago |
|
19
Pharvaris
PHVS
$1.48B
| $23.05 | $34 |
48%
upside
| Overweight |
22 Apr ‘24
1 year ago |
|
20
Genmab
GMAB
$16.9B
| $27.54 | $32 |
16%
upside
| Underweight |
26 Mar ‘24
1 year ago |
|
|
BRNS
21
Barinthus Biotherapeutics
BRNS
$50.5M
| $1.24 | $3.25 |
162%
upside
| Equal-Weight |
25 Sep ‘23
1 year ago |
|
|
ONC
22
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $341.80 | $319 |
7%
downside
| Overweight |
29 Aug ‘23
2 years ago |
|
23
Prime Medicine
PRME
$663M
| $3.72 | $19 |
411%
upside
| Equal-Weight |
14 Aug ‘23
2 years ago |
|
24
Comcast
CMCSA
$125B
| $33.91 | $46 |
36%
upside
| Buy |
24 Apr ‘23
2 years ago |
|
25
Invivyd
IVVD
$239M
| $1.14 | $1 |
12%
downside
| Underweight |
27 Mar ‘23
2 years ago |
|